Aspira Womens Health Stock Performance
AWH Stock | USD 0.13 0.01 10.43% |
The firm shows a Beta (market volatility) of -0.58, which signifies possible diversification benefits within a given portfolio. As returns on the market increase, returns on owning Aspira Womens are expected to decrease at a much lower rate. During the bear market, Aspira Womens is likely to outperform the market. At this point, Aspira Womens Health has a negative expected return of -2.57%. Please make sure to confirm Aspira Womens' value at risk and the relationship between the accumulation distribution and relative strength index , to decide if Aspira Womens Health performance from the past will be repeated at some point in the near future.
Risk-Adjusted Performance
Very Weak
Weak | Strong |
Over the last 90 days Aspira Womens Health has generated negative risk-adjusted returns adding no value to investors with long positions. Despite abnormal performance in the last few months, the Stock's basic indicators remain fairly strong which may send shares a bit higher in April 2025. The recent confusion may also be a sign of long-lasting up-swing for the firm traders. ...more
Last Split Factor 1:15 | Last Split Date 2023-05-12 |
1 | Aspira Womens Healths SWOT analysis stock outlook amid diagnostic growth | 12/17/2024 |
2 | Disposition of 5312 shares by Vos Ellen Oconnor of Aspira Womens subject to Rule 16b-3 | 12/31/2024 |
3 | 12 Health Care Stocks Moving In Thursdays Pre-Market Session - Benzinga | 01/23/2025 |
4 | Acquisition by Torsten Hombeck of 6667 shares of Aspira Womens at 3.2 subject to Rule 16b-3 | 01/30/2025 |
5 | Oral Roberts visits South Dakota following Larkins -point outing | 02/06/2025 |
6 | Aspira Womens Health Announces Appointment of Ellen Beausang to the Board of Directors | 02/11/2025 |
7 | South Dakota takes on UMKC after Larkins 47-point outing | 02/12/2025 |
8 | South Dakota hosts Brown and UMKC | 02/13/2025 |
9 | Aspira Womens Health appoints new CEO and VP of Finance - MSN | 02/27/2025 |
10 | Acquisition by Sandford Nicole of 20000 shares of Aspira Womens at 3.75 subject to Rule 16b-3 | 03/04/2025 |
11 | Acquisition by Schuler Jack W of tradable shares of Aspira Womens at 0.25 subject to Rule 16b-3 | 03/06/2025 |
12 | Aspira Womens Health Announces Closing of 1.37 Million Private Placement of Convertible Notes | 03/11/2025 |
13 | 12 Health Care Stocks Moving In Fridays After-Market Session - Benzinga | 03/14/2025 |
Begin Period Cash Flow | 13.6 M |
Aspira |
Aspira Womens Relative Risk vs. Return Landscape
If you would invest 75.00 in Aspira Womens Health on December 17, 2024 and sell it today you would lose (62.46) from holding Aspira Womens Health or give up 83.28% of portfolio value over 90 days. Aspira Womens Health is generating negative expected returns assuming volatility of 7.813% on return distribution over 90 days investment horizon. In other words, 69% of stocks are less volatile than Aspira, and above 99% of all equities are expected to generate higher returns over the next 90 days. Expected Return |
Risk |
Aspira Womens Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for Aspira Womens' investment risk. Standard deviation is the most common way to measure market volatility of stocks, such as Aspira Womens Health, and traders can use it to determine the average amount a Aspira Womens' price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = -0.3285
Best Portfolio | Best Equity | |||
Good Returns | ||||
Average Returns | ||||
Small Returns | ||||
Cash | Small Risk | Average Risk | High Risk | Huge Risk |
Negative Returns | AWH |
Estimated Market Risk
7.81 actual daily | 69 69% of assets are less volatile |
Expected Return
-2.57 actual daily | 0 Most of other assets have higher returns |
Risk-Adjusted Return
-0.33 actual daily | 0 Most of other assets perform better |
Based on monthly moving average Aspira Womens is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Aspira Womens by adding Aspira Womens to a well-diversified portfolio.
Aspira Womens Fundamentals Growth
Aspira Stock prices reflect investors' perceptions of the future prospects and financial health of Aspira Womens, and Aspira Womens fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Aspira Stock performance.
Return On Equity | -7.23 | ||||
Return On Asset | -1.58 | ||||
Profit Margin | (1.65) % | ||||
Operating Margin | (1.66) % | ||||
Current Valuation | 2.48 M | ||||
Shares Outstanding | 17.68 M | ||||
Price To Earning | 16.82 X | ||||
Price To Book | 5.02 X | ||||
Price To Sales | 0.28 X | ||||
Revenue | 9.15 M | ||||
Gross Profit | 5.21 M | ||||
EBITDA | (16.49 M) | ||||
Net Income | (16.69 M) | ||||
Cash And Equivalents | 20.48 M | ||||
Cash Per Share | 0.18 X | ||||
Total Debt | 2.85 M | ||||
Debt To Equity | 0.24 % | ||||
Current Ratio | 3.26 X | ||||
Book Value Per Share | (0.15) X | ||||
Cash Flow From Operations | (15.89 M) | ||||
Earnings Per Share | (1.15) X | ||||
Market Capitalization | 2.47 M | ||||
Total Asset | 6.26 M | ||||
Retained Earnings | (518.3 M) | ||||
Working Capital | 10.53 M | ||||
Current Asset | 13.53 M | ||||
Current Liabilities | 4.13 M | ||||
About Aspira Womens Performance
By evaluating Aspira Womens' fundamental ratios, stakeholders can gain valuable insights into Aspira Womens' financial health, operational efficiency, and overall profitability, helping them make informed investment and management decisions. For instance, if Aspira Womens has a high ROA and ROE, it suggests that the company is efficiently using its assets and equity to generate substantial profits, making it an attractive investment. Conversely, if Aspira Womens has a low ROA and ROE, it may indicate underlying issues in asset and equity management, signaling a need for operational improvements. Please also refer to our technical analysis and fundamental analysis pages.
Last Reported | Projected for Next Year | ||
Days Of Inventory On Hand | 19.16 | 20.12 | |
Return On Tangible Assets | (3.07) | (2.91) | |
Return On Capital Employed | (18.97) | (18.02) | |
Return On Assets | (3.07) | (2.91) | |
Return On Equity | 6.35 | 6.67 |
Things to note about Aspira Womens Health performance evaluation
Checking the ongoing alerts about Aspira Womens for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for Aspira Womens Health help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.Aspira Womens Health generated a negative expected return over the last 90 days | |
Aspira Womens Health has high historical volatility and very poor performance | |
Aspira Womens Health has some characteristics of a very speculative penny stock | |
The company reported the last year's revenue of 9.15 M. Reported Net Loss for the year was (16.69 M) with profit before taxes, overhead, and interest of 5.21 M. | |
Aspira Womens Health has about 20.48 M in cash with (15.89 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.18, which can makes it an attractive takeover target, given it will continue generating positive cash flow. | |
Aspira Womens Health has a poor financial position based on the latest SEC disclosures | |
Roughly 31.0% of the company shares are held by company insiders | |
Latest headline from news.google.com: 12 Health Care Stocks Moving In Fridays After-Market Session - Benzinga |
- Analyzing Aspira Womens' financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Aspira Womens' stock is overvalued or undervalued compared to its peers.
- Examining Aspira Womens' industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating Aspira Womens' management team can have a significant impact on its success or failure. Reviewing the track record and experience of Aspira Womens' management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of Aspira Womens' stock. These opinions can provide insight into Aspira Womens' potential for growth and whether the stock is currently undervalued or overvalued.
Complementary Tools for Aspira Stock analysis
When running Aspira Womens' price analysis, check to measure Aspira Womens' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Aspira Womens is operating at the current time. Most of Aspira Womens' value examination focuses on studying past and present price action to predict the probability of Aspira Womens' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Aspira Womens' price. Additionally, you may evaluate how the addition of Aspira Womens to your portfolios can decrease your overall portfolio volatility.
Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments | |
Analyst Advice Analyst recommendations and target price estimates broken down by several categories | |
Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings | |
Sync Your Broker Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors. | |
Investing Opportunities Build portfolios using our predefined set of ideas and optimize them against your investing preferences | |
Global Correlations Find global opportunities by holding instruments from different markets | |
Top Crypto Exchanges Search and analyze digital assets across top global cryptocurrency exchanges | |
Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges |